Scopolamine and Vancomycin hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Scopolamine (scopolamine) and Vancomycin hydrochloride (vancomycin hydrochloride). Common drug interactions include blood creatinine increased among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Scopolamine and Vancomycin hydrochloride. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 4,945 Scopolamine users. Check the latest studies of Scopolamine.

What is Vancomycin hydrochloride?

Vancomycin hydrochloride has active ingredients of vancomycin hydrochloride. It is often used in mrsa infection. eHealthMe is studying from 8,399 Vancomycin hydrochloride users. Check the latest studies of Vancomycin hydrochloride.



On Jul, 17, 2026

21 people who take Scopolamine and Vancomycin hydrochloride together, and have interactions are studied.

Scopolamine and Vancomycin hydrochloride drug interactions.

What are the common drug interactions of Scopolamine and Vancomycin Hydrochloride, by gender? *:

female:

  1. Blood creatinine increased
  2. Body temperature increased
  3. Cough
  4. Diarrhoea
  5. Incision site pain
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Pneumonia
  9. Productive cough
  10. Renal hypertension (high blood pressure caused by the kidneys hormonal response)

male:

  1. Haemoglobin decreased
  2. Platelet count decreased
  3. Pyrexia (fever)
  4. Renal failure (kidney dysfunction)
  5. White blood cell count decreased
  6. Blood albumin decreased
  7. Blood glucose increased
  8. Blood urea increased
  9. C-reactive protein increased
  10. Diarrhoea

What are the common drug interactions of Scopolamine and Vancomycin Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Amaurosis (partial or total blindness without visible change in the eye)
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Depressed level of consciousness
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Nystagmus (a condition of involuntary eye movement)
  6. Abdominal pain
  7. Agitation (state of anxiety or nervous excitement)
  8. Aphasia (damage to the parts of the brain that control language)
  9. Ataxia (loss of full control of bodily movements)
  10. Cerebral haemorrhage (bleeding within the brain)

10-19:

n/a

20-29:

  1. Diarrhoea
  2. Blood creatinine increased
  3. Body temperature increased
  4. Cough
  5. Incision site pain
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Pneumonia
  9. Productive cough
  10. Renal hypertension (high blood pressure caused by the kidneys hormonal response)

30-39:

n/a

40-49:

  1. Cystitis haemorrhagic (blood in the urine and painful voiding)
  2. Haematuria (presence of blood in urine)
  3. Haemoglobin decreased
  4. Hydronephrosis (water inside the kidney)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Oedema peripheral (superficial swelling)
  8. Oral infection
  9. Platelet count decreased
  10. Pyrexia (fever)

50-59:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

60+:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Drug hypersensitivity
  3. Dyspnoea (difficult or laboured respiration)
  4. Genital haemorrhage (bleeding from genital)
  5. Hepatic failure (liver failure)
  6. Pruritus (severe itching of the skin)
  7. Renal impairment (severely reduced kidney function)
  8. Skin induration (an abnormally hard spot or area on the skin)

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 47.62%
  2. Cardiac Failure: 6 people, 28.57%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 28.57%
  4. Diarrhea: 6 people, 28.57%
  5. Productive Cough: 6 people, 28.57%
  6. Inflammation: 6 people, 28.57%
  7. Urination - Excessive Volume: 6 people, 28.57%
  8. Constipation: 4 people, 19.05%
  9. Cough: 4 people, 19.05%
  10. Drug Ineffective: 4 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take Scopolamine and Vancomycin hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Scopolamine and Vancomycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Scopolamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Scopolamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on scopolamine and vancomycin hydrochloride (the active ingredients of Scopolamine and Vancomycin hydrochloride, respectively), and Scopolamine and Vancomycin hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: